Tofersen: first approval
A chamber with more collagen is not the same as a demonstrated improvement in a human condition, and the leap from a molecular or tissue-level change to a meaningful health benefit is exactly the leap that clinical trials exist to test and that has not been made for this route
Alteration of transcriptional and post-transcriptional expression of gamma-glutamylcysteine synthetase by diethyl maleate
In conditions characterized by chronic immune dysregulation, such as autoimmunity in Long COVID, the failure of this delicate S-glutathionylation process contributes to sustained tissue damage and cellular miscommunication
GHK-Cu, also known as Copper Peptide GHK-Cu or Copper Tripeptide-1, is a copper-binding tripeptide complex studied in laboratory research involving peptide-copper binding, extracellular matrix signalling, collagen-related research models, wound biology, skin biology and analytical peptide characterisation
The preclinical foundation is strong, particularly for BPC-157 and thymosin beta-4, but the gap between animal evidence and clinical application can only be bridged through rigorous controlled studies in human fracture patients
